Advertisement
Canada markets closed

  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • Bitcoin CAD

    83,063.22
    -2,853.20 (-3.32%)
     

  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     

  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

SOLID BIOSCIENCES (SLDB) INVESTOR ALERT: Lawsuit Investigation

ACCESSWIRE
·1 min read

BOSTON, MA / ACCESSWIRE / September 11, 2020 / Thornton Law Firm LLP is investigating a potential securities class action lawsuit on behalf of shareholders of Solid Biosciences, Inc. (NASDAQ:SLDB). Investors who purchased SLDB shares that are interested in learning more about the potential case are encouraged to visit https://www.tenlaw.com/cases/SLDB. Investors may also contact Thornton Law Firm at shareholder@tenlaw.com, or call 617-531-3917.

FOR MORE INFORMATION, VISIT: https://www.tenlaw.com/cases/SLDB

The investigation is looking into whether Solid Biosciences and certain of its officers or directors have violated the federal securities laws. Since the Company's IPO, Solid's share price has declined significantly from the IPO price. This includes drops that occurred in March 2018 and November 2019 when the FDA put clinical holds on SLDB studies. The lawsuit, if filed, would seek to recover on behalf of investors who purchased SLDB stock pursuant to its IPO.

FOR MORE INFORMATION: https://www.tenlaw.com/cases/SLDB

ADVERTISEMENT

Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of shareholders. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:

Thornton Law Firm LLP
1 Lincoln Street
State Street Financial Center
Boston, MA 02111
http://www.tenlaw.com/cases/SLDB

SOURCE: Thornton Law Firm LLP



View source version on accesswire.com:
https://www.accesswire.com/605784/SOLID-BIOSCIENCES-SLDB-INVESTOR-ALERT-Lawsuit-Investigation